Skip to main content

Research

  • Impulse Control in Parkinson’s Disease

    The University of Birmingham and University Hospitals Birmingham NHS Trust is seeking individuals with Parkinson’s disease who are either not yet taking medication or taking Ropinirole to be part of a research study looking at mechanisms which control movement.
    Eligible patients that sign up to the study will be asked to attend two 3-hour sessions at the University of Birmingham. For those that attend, compensation is paid at £10/hr for time and travel expense.
    For more information and contact details to sign-up please contact Aliya.

    Phone
    07557 028358

    Email
    ach722@bham.ac.uk

  • GaitSmart – Health Innovation Network

    GaitSmart helps people prevent and manage musculoskeletal issues.
    Innovative, motion-sensor, gait analysis delivers data driven reports and personalised intervention plans quickly and easily to help improve mobility.

    Website
    GaitSmart MSK

  • Duration UTI – NIHR

    A trial open to females aged 18+
    This research aims to find the shortest antibiotic treatment duration needed to treat urinary tract infections (UTIs) in women. 
    Duration UTI is a phase IV open-label, parallel-group, multi-arm “durations” randomised controlled trial.
    This trial aims to find the shortest antibiotic treatment duration needed to treat urinary tract infections (UTIs) in women and also to look at the impact of the treatment duration on antibiotic resistance.
    There are two sub-trials which we are recruiting in Primary Care:
    Cystitis
    Pyelonephritis
    If you book an appointment for a UTI or cystitis, patients will be asked to provide a sample and sign a consent to take part in the study prior to starting a course of antibiotics.
    Your GP or nurse prescriber will provide more information during your appointment.
    For more information about the research project, please visit the Primary Health Care Trials website.

  • STARFISH – NIHR

    Hearing loss is a common and disabling condition that may result from problems with the cochlea, the inner ear structure that senses sound and sends information to the brain. Loss of hearing due to damage to the cochlea can occur suddenly and without an obvious cause, a condition described as sudden sensorineural hearing loss (SSNHL). SSNHL can range from a mild hearing loss to a completely deaf ear, which can make it difficult to understand people talking on the affected side. Recovery of hearing following SSNHL may be helped by urgent treatment with steroids, but crucially we do not know if these work best given as tablets or by an injection through the ear drum. If SSNHL is identified more than a few weeks after it occurs, steroids may have little effect. A major problem is that patients with SSNHL may not be referred to Ear, Nose and Throat (ENT) surgeons in time to benefit from steroid treatment (within four weeks), due to delays in the hearing loss being recognised or referred by general practitioners (GPs). Sudden hearing loss is rare and we usually do not know why it happens. Steroids are the best treatment to try and improve the hearing, but we do not know whether it is best to give them by mouth or by an injection through the ear drum. If you have sudden hearing loss please call the Practice and arrange an appointment with a GP or Nurse Prescriber. Further information can be found on the study website.

  • AD-HOC – NIHR

    This clinical trial aims to improve asthma care by testing whether online peer support can help patients better manage their condition. The support is delivered through the nurse-moderated online asthma community run by the Asthma + Lung UK charity. In the UK, 5.4 million adults live with asthma, many of whom struggle with symptoms that affect their quality of life and lead to increased healthcare use. Although online health communities (OHCs) provide valuable peer support and self-management resources, they are rarely recommended in primary care.

    Eligible patients will be sent a questionnaire, once completed, patients will be booked in with our respiratory nurse. All participants attending the practice appointment will receive £10.

  • IBHO – Improving Black health Outcomes

    The aim of the IBHO BioResource is to research the social and biological causes, and impacts, of a broad range of health conditions and illnesses in people from Black communities in the United Kingdom (UK). These include disorders that affect people from Black communities at increased rates, such as diabetes and pregnancy/childbirth complications, but also conditions that almost exclusively affect those from Black communities such as sickle cell disease. The IBHO Bioresource is also designed to examine some conditions such as anxiety, depression, and dermatological problems, about which not enough is known in Black communities. The IBHO BioResource aims to improve our understanding of how and why these different health conditions that affect the Black community occur. We also want to help researchers understand what the best assessments are to use to accurately identify these conditions in Black people, and how to use research findings to improve and develop treatments that meet the specific health needs of Black communities.

    All participants will be offered a £15 voucher following consent.

Page published: 18 October 2024
Last updated: 12 June 2025